These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7010975)

  • 1. Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone.
    Marcus FI; Fontaine GH; Frank R; Grosgogeat Y
    Am Heart J; 1981 Apr; 101(4):480-93. PubMed ID: 7010975
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical use and pharmacology of amiodarone.
    Heger JJ; Prystowsky EN; Miles WM; Zipes DP
    Med Clin North Am; 1984 Sep; 68(5):1339-66. PubMed ID: 6387328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Amiodarone, a class 3 antiarrhythmic agent: current electrophysiological and therapeutic aspects].
    Depelchin P; Schoenfeld P; Stoupel E; Degré S
    Rev Med Brux; 1986 Feb; 7(2):92-103. PubMed ID: 3515481
    [No Abstract]   [Full Text] [Related]  

  • 4. Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects.
    Zipes DP; Prystowsky EN; Heger JJ
    J Am Coll Cardiol; 1984 Apr; 3(4):1059-71. PubMed ID: 6368644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone: a unique antiarrhythmic agent.
    Sloskey GE
    Clin Pharm; 1983; 2(4):330-40. PubMed ID: 6349912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiodarone in long term management of refractory cardiac tachyarrhythmias.
    Lubbe WF; Mercer CJ; Roche AH; Lowe JB
    N Z Med J; 1981 Jan; 93(676):31-5. PubMed ID: 6940024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newer antiarrhythmic drugs.
    Coumel P; Krikler D; Rosen MR; Wellens HJ; Zipes DP
    Pacing Clin Electrophysiol; 1978 Oct; 1(4):521-8. PubMed ID: 95646
    [No Abstract]   [Full Text] [Related]  

  • 8. Electrophysiologic effects of amiodarone in tachyarrhythmias.
    Liu PH; Lin CC; Ko GC; Wang DJ; Shieh SM; Sung PK
    Taiwan Yi Xue Hui Za Zhi; 1985 Jul; 84(7):759-75. PubMed ID: 3864917
    [No Abstract]   [Full Text] [Related]  

  • 9. Aprindine (AC 1802), a new anti-arrhythmic drug.
    Kesteloot H; Van Mieghem W; De Geest H
    Acta Cardiol; 1973; 28(2):145-65. PubMed ID: 4121909
    [No Abstract]   [Full Text] [Related]  

  • 10. Amiodarone therapy for life threatening or refractory cardiac arrhythmias.
    Johns JA; Harper RW; Currie PJ; Federman J; Anderson ST; Pitt A
    Aust N Z J Med; 1983 Jun; 13(3):248-56. PubMed ID: 6579938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical use of Cordarone].
    Preobrazhenskiĭ DV; Ryndina MG; Blizniak GV
    Kardiologiia; 1979 Apr; 19(4):107-12. PubMed ID: 35642
    [No Abstract]   [Full Text] [Related]  

  • 12. Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias.
    Rowland E; Krikler DM
    Br Heart J; 1980 Jul; 44(1):82-90. PubMed ID: 7426165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of amiodarone as an antiarrhythmic agent.
    Rosenbaum MB; Chiale PA; Halpern MS; Nau GJ; Przybylski J; Levi RJ; Lázzari JO; Elizari MV
    Am J Cardiol; 1976 Dec; 38(7):934-44. PubMed ID: 793369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical applications of antiarrhythmic drugs.
    Lavenne F; de Jonghe D
    Acta Cardiol Suppl; 1980; (25):27-42. PubMed ID: 6155012
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of oral amiodarone on rate-dependent changes in refractoriness in patients with Wolff-Parkinson-White syndrome.
    Brugada P; Wellens HJ
    Am J Cardiol; 1985 Nov; 56(13):863-6. PubMed ID: 4061328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The electrophysiology and pharmacology of verapamil, flecainide, and amiodarone: correlations with clinical effects and antiarrhythmic actions.
    Singh BN; Nademanee K; Josephson MA; Ikeda N; Venkatesh N; Kannan R
    Ann N Y Acad Sci; 1984; 432():210-35. PubMed ID: 6395762
    [No Abstract]   [Full Text] [Related]  

  • 17. New perspectives in the pharmacologic therapy of cardiac arrhythmias.
    Singh BN; Collett JT; Chew CY
    Prog Cardiovasc Dis; 1980; 22(4):243-301. PubMed ID: 6986060
    [No Abstract]   [Full Text] [Related]  

  • 18. Ten years of experience with amiodarone.
    Rosenbaum MB; Chiale PA; Haedo A; Lázzari JO; Elizari MV
    Am Heart J; 1983 Oct; 106(4 Pt 2):957-64. PubMed ID: 6613843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceleration of ventricular rate by fibrillation associated with the Wolff-Parkinson-White syndrome.
    Sheinman BD; Evans T
    Br Med J (Clin Res Ed); 1982 Oct; 285(6347):999-1000. PubMed ID: 6812745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
    Coumel P; Leclercq JF; Assayag P
    Am J Cardiol; 1984 Nov; 54(9):60D-66D. PubMed ID: 6208770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.